FENNEC PHARMACEUTICALS INC.
Ticker: 1211583
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 15.11+21.3% | 12.46+29.1% | 9.65+10.3% | 8.75+25.5% | 6.97-4.0% | 7.26-71.4% | 25.38+289.3% | 6.52 |
| Total Income | 15.11+21.3% | 12.46+29.1% | 9.65+10.3% | 8.75+25.5% | 6.97-4.0% | 7.26-71.4% | 25.38+289.3% | 6.52 |
| EXPENSES | ||||||||
| Expenditure | 15.23+20.4% | 12.65+2.2% | 12.38+29.5% | 9.56-21.5% | 12.18-1.0% | 12.30+5.8% | 11.63+54.4% | 7.53 |
| PROFIT | ||||||||
| Net Profit | 0.20+131.3% | -0.64+79.7% | -3.15-169.2% | -1.17+79.6% | -5.74-3.4% | -5.55-143.2% | 12.84+786.6% | -1.87 |
| KEY METRICS | ||||||||
| OPM % | -0.79%+0.73pp | -1.52%+26.79pp | -28.30%-19.07pp | -9.23%+65.36pp | -74.59%-5.20pp | -69.39%-123.54pp | 54.16%+69.77pp | -15.61% |
| NPM % | 1.33%+6.45pp | -5.12%+27.54pp | -32.66%-19.34pp | -13.31%+68.92pp | -82.23%-5.77pp | -76.47%-127.05pp | 50.59%+79.24pp | -28.66% |
| EPS | 0.01+150.0% | -0.02+81.8% | -0.11-175.0% | -0.04+81.0% | -0.21-5.0% | -0.20-148.8% | 0.41+685.7% | -0.07 |
Corporate Events
Board MeetingFENC
202610Jun
Board Meeting
Annual Meeting of Shareholders to elect directors, appoint a…
SEC Filing ↗ Board MeetingFENC
202618May
Board Meeting
Compensation Committee approved stock option grants to three…
SEC Filing ↗ Board MeetingFENC
202627Apr
Board Meeting
Director Retirement — Rostislav Raykov to retire from the Bo…
SEC Filing ↗